We immobilize an antibody to the affinity pipette which then allows us to extract the protein from human plasma or urine. This allows us to assess variations in human proteins among and within
populations using mass spectrometry. It can facilitate
clinical proteomics in discovery and validation of protein biomarkers
that can be used for early diagnosis of
cancer, monitoring of disease progression, and assessment
of therapy.
No comments:
Post a Comment